81 related articles for article (PubMed ID: 21420224)
61. Ascorbic acid ameliorates oxidative stress and inflammation in dextran sulfate sodium-induced ulcerative colitis in mice.
Yan H; Wang H; Zhang X; Li X; Yu J
Int J Clin Exp Med; 2015; 8(11):20245-53. PubMed ID: 26884937
[TBL] [Abstract][Full Text] [Related]
62. Effect of EPA and vitamin C on superoxide dismutase, glutathione peroxidase, total antioxidant capacity and malondialdehyde in type 2 diabetic patients.
Mahmoudabadi MM; Rahbar AR
Oman Med J; 2014 Jan; 29(1):39-45. PubMed ID: 24498481
[TBL] [Abstract][Full Text] [Related]
63. Latest in vitro and in vivo models of celiac disease.
Stoven S; Murray JA; Marietta EV
Expert Opin Drug Discov; 2013 Apr; 8(4):445-57. PubMed ID: 23293929
[TBL] [Abstract][Full Text] [Related]
64. Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.
Ferretti G; Bacchetti T; Masciangelo S; Saturni L
Nutrients; 2012 Apr; 4(4):243-57. PubMed ID: 22606367
[TBL] [Abstract][Full Text] [Related]
65. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients.
León AJ; Garrote JA; Blanco-Quirós A; Calvo C; Fernández-Salazar L; Del Villar A; Barrera A; Arranz E
Clin Exp Immunol; 2006 Dec; 146(3):479-85. PubMed ID: 17100768
[TBL] [Abstract][Full Text] [Related]
66. IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease.
Zanzi D; Stefanile R; Santagata S; Iaffaldano L; Iaquinto G; Giardullo N; Lania G; Vigliano I; Vera AR; Ferrara K; Auricchio S; Troncone R; Mazzarella G
Am J Gastroenterol; 2011 Jul; 106(7):1308-17. PubMed ID: 21468011
[TBL] [Abstract][Full Text] [Related]
67. Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease.
Fina D; Sarra M; Caruso R; Del Vecchio Blanco G; Pallone F; MacDonald TT; Monteleone G
Gut; 2008 Jul; 57(7):887-92. PubMed ID: 17965065
[TBL] [Abstract][Full Text] [Related]
68. Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease.
Di Sabatino A; Pickard KM; Gordon JN; Salvati V; Mazzarella G; Beattie RM; Vossenkaemper A; Rovedatti L; Leakey NA; Croft NM; Troncone R; Corazza GR; Stagg AJ; Monteleone G; MacDonald TT
Gastroenterology; 2007 Oct; 133(4):1175-87. PubMed ID: 17919493
[TBL] [Abstract][Full Text] [Related]
69. Selective inhibition of the gliadin-specific, cell-mediated immune response by transamidation with microbial transglutaminase.
Lombardi E; Bergamo P; Maurano F; Bozzella G; Luongo D; Mazzarella G; Rotondi Aufiero V; Iaquinto G; Rossi M
J Leukoc Biol; 2013 Apr; 93(4):479-88. PubMed ID: 23108099
[TBL] [Abstract][Full Text] [Related]
70. Celiac disease pathogenesis: the proinflammatory cytokine network.
Garrote JA; Gómez-González E; Bernardo D; Arranz E; Chirdo F
J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S27-32. PubMed ID: 18667914
[TBL] [Abstract][Full Text] [Related]
71. Vaccination and other antigen-specific immunomodulatory strategies in celiac disease.
Rossi M
Dig Dis; 2015; 33(2):282-289. PubMed ID: 25925936
[TBL] [Abstract][Full Text] [Related]
72. Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients.
Bernardo D; Martínez-Abad B; Vallejo-Diez S; Montalvillo E; Benito V; Anta B; Fernández-Salazar L; Blanco-Quirós A; Garrote JA; Arranz E
Allergol Immunopathol (Madr); 2012; 40(1):3-8. PubMed ID: 21420224
[TBL] [Abstract][Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
